|
|
| Line 547: |
Line 547: |
|
| |
|
| ===Polymorphous low-grade tumor of the young (PLNTY)=== | | ===Polymorphous low-grade tumor of the young (PLNTY)=== |
| * No official WHO entity.<ref name="pmid27812792">{{cite journal |authors=Huse JT, Snuderl M, Jones DT, Brathwaite CD, Altman N, Lavi E, Saffery R, Sexton-Oates A, Blumcke I, Capper D, Karajannis MA, Benayed R, Chavez L, Thomas C, Serrano J, Borsu L, Ladanyi M, Rosenblum MK |title=Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway |journal=Acta Neuropathol |volume=133 |issue=3 |pages=417–429 |date=March 2017 |pmid=27812792 |pmc=5325850 |doi=10.1007/s00401-016-1639-9 |url=}}</ref> | | * [[Pediatric-type diffuse low-grade glioma#Diffuse low-grade glioma, MAPK pathway-altered|Polymorphous low-grade tumor of the young (PLNTY)]] |
| * Epilepsy-associated.
| |
| * Oligodendroglioma-like histologic features.
| |
| * Frequently CD34+ve.
| |
| * FGFR3-TACC3 and FGFR2-CTNNA3 fusions.
| |
|
| |
|
| ==Pineal tumours== | | ==Pineal tumours== |